All sterile products within expiry
Published October 15, 2014 · Recall initiated: July 18, 2014
Summary
FDA records drug Class II recall D-0012-2015, published October 15, 2014 and initiated July 18, 2014. Recalling firm: Unique Pharmaceutical, Ltd; Status: Terminated; Reported quantity: 325,225 units (syringes, vials, bags); Lot: All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Unique Pharmaceutical, Ltd
- Distributor
- Nationwide
- Lot
- All Lots
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAN-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133October 15, 2014
- FDATruvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only,October 15, 2014
- FDAMETOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, (present as the hydrochloride), 10 mL cups, Rx only. ManufacturedOctober 15, 2014
- FDAE-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g (0.14 oz), 50 -count box, Rx Only, ManufacturedOctober 15, 2014
- FDAMetoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles, Rx only, Mfg by MylanOctober 15, 2014
- FDANORepinephrine 4 mg in 250 mL Sodium Chloride0.9%, For IV Use Only, Flexible Bag, Rx only, UNIQUESeptember 24, 2014
Questions about this recall
Was All sterile products within expiry recalled?
Yes. FDA published recall D-0012-2015 on October 15, 2014. Reported hazard: Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit